Melatonin: Possible implications for the postoperative and critically ill patient

Intensive Care Medicine

Volumn 32, Issue 3, 2006, Pages 371-379

  Bourne, Richard S ^a   Mills, Gary H ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Circadian rhythm; Critical illness; Delirium; Melatonin; Sepsis; Sleep disorders

Indexed keywords

BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CORTICOSTEROID; LOCAL ANESTHETIC AGENT; MELATONIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; VALPROIC ACID;

ANTIOXIDANT ACTIVITY; CIRCADIAN RHYTHM; CORRELATION ANALYSIS; CRITICAL ILLNESS; DELIRIUM; DISEASE ASSOCIATION; HEART PROTECTION; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; MULTIPLE ORGAN FAILURE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; REVIEW; SEPSIS; SLEEP DISORDER; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; TREATMENT INDICATION;

CRITICAL ILLNESS; GREAT BRITAIN; HUMANS; INTENSIVE CARE UNITS; MELATONIN; POSTOPERATIVE CARE;

EID: 33344464120     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-0061-x     Document Type: Review

References (84)

1. Claustrat B, Brun J, David M, Sassolas G, Chazot G (1992) Melatonin and jet lag: confirmatory result using a simplified protocol. Biol Psychiatry 32:705-711
2. Lissoni P, Barni S, Ardizzoia A, Paolorossi F, Crispino S, Tancini G, Tisi E, Archili C, De Toma D, Pipino G (1992) Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin. Oncology 49:336-339
3. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD (1991) Delayed sleep phase syndrome response to melatonin. Lancet 337:1121-4
4. Sack RL, Brandes RW, Kendall AR, Lewy AJ (2000) Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 343:1070-7
5. Garfinkel D, Laudon M, Nof D, Zisapel N (1995) Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 346:541-544
6. Reiter RJ, Tan DX, Sainz RM, Mayo JC, Lopez-Burillo S (2002) Melatonin: Reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 54:1299-1321
7. Naguib M, Samarkandi AH (1999) Premedication with melatonin: a double-blind, placebo-controlled comparison with midazolam. Br J Anaesth 82:875-80
8. Naguib M, Hammond DL, Schmid PG 3rd, Baker MT, Cutkomp J, Queral L, Smith T (2003) Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol. Br J Anaesth 90:504-507
9. Ryan DW (2002) Tried any melatonin lately? Care of the Critically Ill 18:132
10. Lane EA, Moss HB (1985) Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J Clin Endocrinol METAB 61:1214-1216
11. Sharma M, Palacios Bois J, Schwartz G, Iskandar H, Thakur M, Quirion R, Nair NP (1989) Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry 25:305-319
12. Bubenik GA (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47:2336-2348
13. Sack RL, Hughes RJ, Edgar DM, Lewy AJ (1997) Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep 20:908-915
14. Pang SF, Dubocovich ML, Brown GM (1993) Melatonin receptors in peripheral tissues: a new area of melatonin research. Biol Signals 2:177-180
15. Di WL, Djahanbakhch O, Kadva A, Street C, Silman R (1999) The pineal and extra-pineal origins of 5-sulphatoxy N-acetyl-serotonin in humans. J Pineal Res 26:221-226
16. Di WL, Kadva A, Johnston A, Silman R (1997) Variable bioavailability of oral melatonin. N Engl J Med 336:1028-1029
17. DeMuro RL, Nafziger AN, Blask DE, Menhinick AM, Bertino JS Jr (2000) The absolute bioavailability of oral melatonin. J Clin Pharmacol 40:781-784
18. Hartter S, Ursing C, Morita S, Tybring G, von Bahr C, Christensen M, Rojdmark S, Bertilsson L (2001) Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study. Clin Pharmacol Ther 70:10-16
19. Bojkowski CJ, Arendt J, Shih MC, Markey SP (1987) Melatonin secretion in humans assessed by measuring its metabolite 6-sulphatoxymelatonin. Clin Chem 33:1343-1348
20. Mallo C, Zadan R, Galy G, Vermeulen E, Brun J, Chazot G, Claustrat B (1990) Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur J Clin Pharmacol 38:297-301
21. Iguchi H, Kato KI, Ibayashi H (1982) Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol METAB 54:1025-1027
22. Vakkuri O, Leppaluoto J, Kauppila A (1985) Oral administration and distribution of melatonin in human serum, saliva and urine. Life Sci 37:489-495
23. Aldhous M, Franey C, Wright J, Arendt J (1985) Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol 19:517-521
24. Reiter RJ, Tan DX (2003) What constitutes a physiological concentration of melatonin? J Pineal Res 34:79-80
25. Selmaoui B, Touitou Y (2003) Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci 73:3339-3349
26. Reber A, Huber PR, Ummenhofer W, Gurtler CM, Zurschmiede C, Drewe J, Schneider M (1998) General anaesthesia for surgery can influence circulating melatonin during daylight hours. Acta Anaesthesiol Scand 42:1050-1056
27. Uchida K, Aoki T, Takahashi K, Iigo M, Hattori A, Suzuki T (1995) Perioperative plasma melatonin levels in patients with cardiac and esophageal surgery. St Marianna Med J 23:353-360
28. Guo X, Kuzumi E, Charman SC, Vuylsteke A (2002) Perioperative melatonin secretion in patients undergoing coronary artery bypass grafting. Anesth Analg 94:1085-1091
29. Uchida K, Aoki T, Ishizuka B (1999) Postoperative delirium and plasma melatonin. Med Hypotheses 53:103-106
30. Govitrapong P, Pariyanonth M, Ebadi M (1992) The presence and actions of opioid receptors in bovine pineal gland. J Pineal Res 13:124-132
31. Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L (1988) Melatonin secretion related to side effects of beta-blockers from the central nervous system. Acta Med Scand 223:525-530
32. Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W (1999) Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 55:111-115
33. McIntyre IM, Burrows GD, Norman TR (1988) Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biol Psychiatry. 24:108-112
34. Monteleone P, Forziati D, Orazzo C, Maj M (1989) Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans. J Pineal Res 6:253-258
35. Yuwiler A (1989) Effects of steroids on serotonin-N-acetyltransferase activity of pineals in organ culture. J Neurochem 52:46-53
36. Iuvone PM, Besharse JC (1986) Involvement of calcium in the regulation of serotonin N- acetyltransferase in retina. J Neurochem 46:82-88
37. Meyer AC, Nieuwenhuis JJ, Kociszewska VJ, Joubert WS, Meyer BJ (1986) Dihydropyridine calcium antagonists depress the amplitude of the plasma melatonin cycle in baboons. Life Sci 39:1563-1569
38. Murphy PJ, Myers BL, Badia P (1996) Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 59:133-139
39. Munoz-Hoyos A, Fernandez-Garcia JM, Molina-Carballo A, Macias M, Escames G, Ruiz-Cosano C, Acuna-Castroviejo D (2000) Effect of clonidine on plasma ACTH, cortisol and melatonin in children. J Pineal Res 29:48-53
40. Monteleone P, Tortorella A, Borriello R, Natale M, Cassandro P, Maj M (1997) Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans. Biol Psychiatry 41:336-341
41. Karkela J, Vakkuri O, Kaukinen S, Huang WQ, Pasanen M (2002) The influence of anaesthesia and surgery on the circadian rhythm of melatonin. Acta Anaesthesiol Scand 46:30-36
42. Messner M, Huether G, Lorf T, Ramadori G, Schworer H (2001) Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci 69:543-551
43. Cronin AJ, Keifer JC, Davies MF, King TS, Bixler EO (2000) Melatonin secretion after surgery. Lancet 356:1244-1245
44. Nishimura S, Fujino Y, Shimaoka M, Hagihira S, Taenaka N, Yoshiya I (1998) Circadian secretion patterns of melatonin after major surgery. J Pineal Res 25:73-77
45. Miyazaki T, Kuwano H, Kato H, Ando H, Kimura H, Inose T, Ohno T, Suzuki M, Nakajima M, Manda R, Fukuchi M, Tsukada K (2003) Correlation between serum melatonin circadian rhythm and intensive care unit psychosis after thoracic esophagectomy. Surgery 133:662-668
46. Derenzo J, Macknight B, DiVittore NA, Bonafide CP, Cronin AJ (2005) Postoperative elevated cortisol excretion is not associated with suppression of 6-sulfatoxymelatonin excretion. Acta Anaesthesiol Scand 49:52-57
47. Kellner M, Yassouridis A, Manz B, Steiger A, Holsboer F, Wiedemann K (1997) Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers - a potential link to low-melatonin syndrome in depression? Neuroendocrinology 65:284-290
48. Rosenberg-Adamsen S, Kehlet H, Dodds C, Rosenberg J (1996) Postoperative sleep disturbances: mechanisms and clinical implications. Br J Anaesth 76:552-559
49. Mundigler G, Delle-Karth G, Koreny M, Zehetgruber M, Steindl-Munda P, Marktl W, Ferti L, Siostrzonek P (2002) Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit Care Med 30:536-540
50. Parfitt AG, Klein DC (1976) Sympathetic nerve endings in the pineal gland protect against acute stress-induced increase in N-acetyltransferase (EC 2.3.1.5.) activity. Endocrinology 99:840-851
51. Berlin I, Touitou Y, Guillemant S, Danjou P, Puech AJ (1995) Beta-adrenoceptor agonists do not stimulate daytime melatonin secretion in healthy subjects. A double blind placebo controlled study. Life Sci 56:325-331
52. Frisk U, Olsson J, Nylen P, Hahn RG (2004) Low melatonin excretion during mechanical ventilation in the intensive care unit. Clin Sci 107:47-53
53. Sam S, Corbridge TC, Mokhlesi B, Comellas AP, Molitch ME (2004) Cortisol levels and mortality in severe sepsis. Clin Endocrinol (Oxf) 60:29-35
54. Olofsson K, Alling C, Lundberg D, Malmros C (2004) Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients. Acta Anaesthesiol Scand 48:679-684
55. Gabor JY, Cooper AB, Hanly PJ (2001) Sleep disruption in the intensive care unit. Curr Opin Crit Care 7:21-27
56. Cooper AB, Thornley KS, Young GB, Slutsky AS, Stewart TE, Hanly PJ (2000) Sleep in critically ill patients requiring mechanical ventilation. Chest 117:809-818
57. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Balaum H, Shenkman L (1999) Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern. Am J Med Sci 317:278-281
58. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Shenkman L (2000) Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int 17:71-76
59. MacFarlane JG, Cleghorn JM, Brown GM, Streiner DL (1991) The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: A preliminary study. Biol Psychiatry 30:371-376
60. Helfrich E, Neef C, Hylkema BS, Wilts G, Merkus FWHM (2004) Obtaining a normal sleep-wake pattern: Intranasal administration of melatonin in intensive care patients. Pharm Weekbl 139:82-85
61. Bourne RS, Mills GH (2004) Sleep disruption in critically ill patients - pharmacological considerations. Anaesthesia 59:374-384
62. Zhdanova IV, Wurtman RJ, Morabito C, Piotrovska VR, Lynch HJ (1996) Effects of low oral doses of melatonin, given 2-4 h before habitual bedtime, on sleep in normal young humans. Sleep 19:423-431
63. Paul MA, Gray G, Kenny G, Pigeau RA (2003) Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 74:1263-1270
64. Cajochen C, Kräuchi K, Wirz Justice A (2003) Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 15:432-437
65. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS (2004) Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291:1753-1762
66. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray-Michael J, Perazzi WT, Lumb PD (2002) Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30:119-141
67. Miles A, Philbrick DRS (1988) Melatonin and psychiatry. Biol Psychiatry 23:405-425
68. Shigeta H, Yasui A, Nimura Y, Machida N, Kageyama M, Miura M, Menjo M, Ikeda K (2001) Postoperative delirium and melatonin levels in elderly patients. Am J Surg 182:449-454
69. Balan S, Leibovitz A, Zila SO, Ruth M, Chana W, Yassica B, Rahel B, Richard G, Neumann E, Blagman B, Habot B (2003) The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci 15:363-366
70. Lewis MC, Barnett SR (2004) Postoperative delirium: The tryptophan dyregulation model. Med Hypotheses 63:402-406
71. Hanania M, Kitain E (2002) Melatonin for treatment and prevention of postoperative delirium. Anesth Analg 94:338-339
72. McGuire BE, Basten CJ, Ryan CJ, Gallagher J (2000) Intensive care unit syndrome: a dangerous misnomer. Arch Intern Med 160:906-909
73. Lundstrom M, Edlund A, Karlsson S, Brannstrom B, Bucht G, Gustafson Y (2005) A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc 53:622-628
74. Macdonald J, Galley HF, Webster NR (2003) Oxidative stress and gene expression in sepsis. Br J Anaesth 90:221-232
75. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK (1996) Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 24:1179-1183
76. Pascual C, Karzai W, Meier-Hellmann A, Oberhoffer M, Horn A, Bredle D, Reinhart K (1998) Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 26:705-709
77. Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A (1995) Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 293:327-334
78. Yerer MB, Aydogan S, Yapislar H, Yalcin O, Kuru O, Baskurt OK (2003) Melatonin increases glutathione peroxidase activity and deformability of erythrocytes in septic rats. J Pineal Res 35:138-139
79. Paskaloglu K, Sener G, Kapucu C, Ayanoglu-Dulger G (2004) Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci 74:1093-1104
80. Acikel M, Buyukokuroglu ME, Aksoy H, Erdogan F, Erol MK (2003) Protective effects of melatonin against myocardial injury induced by isoproterenol in rats. J Pineal Res 35:75-79
81. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I (2001) Effects of melatonin treatment in septic newborns. Pediatr Res 50:756-760
82. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150
83. Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C (1999) Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 50:271-279
84. Albuszies G, Bruckner UB (2003) Antioxidant therapy in sepsis. Intensive Care Med 29:1632-1636